Contact
searchSearch
HMP Global

September 2014 - FRMC

Department
Specialty Pharmacy Trends Report: Rheumatoid Arthritis
09/22/2014
Rheumatoid arthritis (RA) is a chronic inflammatory disorder that primarily affects small joints in the hands and feet.
Rheumatoid arthritis (RA) is a chronic inflammatory disorder that primarily affects small joints in the hands and feet.
Rheumatoid arthritis (RA) is a...
09/22/2014
First Report Managed Care
Department
Specialty Pharmacy Trends Report: Psoriasis/Psoriatic Arthritis
09/22/2014
Psoriasis is an autoimmune disease in which excessive skin cell growth results in thick, discolored patches of skin. Some individuals with psoriasis may also develop psoriatic arthritis (PsA), in which the immune system attacks the joints,...
Psoriasis is an autoimmune disease in which excessive skin cell growth results in thick, discolored patches of skin. Some individuals with psoriasis may also develop psoriatic arthritis (PsA), in which the immune system attacks the joints,...
Psoriasis is an autoimmune...
09/22/2014
First Report Managed Care
Department
Specialty Pharmacy Trends Report: Oncology
09/22/2014
According to the CDC, globally, about 14 million people each year are diagnosed with cancer, while 8 million people die from the disease.
According to the CDC, globally, about 14 million people each year are diagnosed with cancer, while 8 million people die from the disease.
According to the CDC, globally,...
09/22/2014
First Report Managed Care
Data Show Improved HbA1c with Canagliflozin
09/22/2014
San Francisco—Clinical trials of canagliflozin improved hemoglobin A1c (HbA1c) in patients with type 2 diabetes compared with sitagliptin, according to data from 2 studies presented at the ADA meeting during a product theater sponsored by...
San Francisco—Clinical trials of canagliflozin improved hemoglobin A1c (HbA1c) in patients with type 2 diabetes compared with sitagliptin, according to data from 2 studies presented at the ADA meeting during a product theater sponsored by...
San Francisco—Clinical trials of...
09/22/2014
First Report Managed Care
Research Expanding into Diabetic Kidney Disease
09/22/2014
San Francisco—Diabetic kidney disease is 1 of the more common long-term complications of diabetes.
San Francisco—Diabetic kidney disease is 1 of the more common long-term complications of diabetes.
San Francisco—Diabetic kidney...
09/22/2014
First Report Managed Care
Managing Charcot Foot
09/22/2014
Charcot foot is a significant complication that individuals with diabetes develop in relation to peripheral neuropathy of the foot.
Charcot foot is a significant complication that individuals with diabetes develop in relation to peripheral neuropathy of the foot.
Charcot foot is a significant...
09/22/2014
First Report Managed Care
Changing Patient Behavior Can Lead to Effective Coping
09/22/2014
San Francisco—Diabetes care requires a truly collaborative approach where patients and clinicians relate as equals, according to David G. Marrero, PhD, JO Ritchey Society, professor of medicine, Indiana University School of Medicine. Dr....
San Francisco—Diabetes care requires a truly collaborative approach where patients and clinicians relate as equals, according to David G. Marrero, PhD, JO Ritchey Society, professor of medicine, Indiana University School of Medicine. Dr....
San Francisco—Diabetes care...
09/22/2014
First Report Managed Care
Newly-Approved Empagliflozin for Obese Patients with Type 2 Diabetes
09/22/2014
San Francisco—After 52 weeks of treatment, obese patients with type 2 diabetes who received empagliflozin as an add-on therapy to daily insulin injections had improved glucose control, experienced weight loss, and had no increase in...
San Francisco—After 52 weeks of treatment, obese patients with type 2 diabetes who received empagliflozin as an add-on therapy to daily insulin injections had improved glucose control, experienced weight loss, and had no increase in...
San Francisco—After 52 weeks of...
09/22/2014
First Report Managed Care
Emerging Therapies in Diabetic Retinopathy
09/22/2014
San Francisco—Diabetic retinopathy, a term used for all abnormalities of the small blood vessels of the retina caused by diabetes, is estimated to be the most frequent cause of new cases of blindness among adults 20 to 74 years of age. All...
San Francisco—Diabetic retinopathy, a term used for all abnormalities of the small blood vessels of the retina caused by diabetes, is estimated to be the most frequent cause of new cases of blindness among adults 20 to 74 years of age. All...
San Francisco—Diabetic...
09/22/2014
First Report Managed Care
Experts Discuss Diabetic Dyslipidemia
09/22/2014
San Francisco—Diabetic dyslipidemia is a well-recognized factor for atherosclerotic cardiovascular disease. Characteristic dyslipidemia of insulin resistance and type 2 diabetes presents with a triad of lipid abnormalities, including...
San Francisco—Diabetic dyslipidemia is a well-recognized factor for atherosclerotic cardiovascular disease. Characteristic dyslipidemia of insulin resistance and type 2 diabetes presents with a triad of lipid abnormalities, including...
San Francisco—Diabetic...
09/22/2014
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

What's Trending?

News
Biotechnology Initial Public Offerings Soar in 2013
02/13/2014
New York—After several poor years, the biotechnology industry rebounded in 2013 with 45 initial public offerings (IPOs) of biotechnology companies and more money flowing into the sector. It was the most activity in the sector since 2000, and...
New York—After several poor years, the biotechnology industry rebounded in 2013 with 45 initial public offerings (IPOs) of biotechnology companies and more money flowing into the sector. It was the most activity in the sector since 2000, and...
New York—After several poor...
02/13/2014
First Report Managed Care
News
Study: Pediatric Patients Benefit From PCMH Utilization
03/22/2017
Researchers argue that public funding efforts should be invested in improving the use of patient centered medical homes for children covered under public insurance, or those who have no insurance at all.
Researchers argue that public funding efforts should be invested in improving the use of patient centered medical homes for children covered under public insurance, or those who have no insurance at all.
Researchers argue that public...
03/22/2017
First Report Managed Care
News
High Deductible Health Plans Associated With No Change in Asthma Care
10/26/2021
Authors noted that enrollment in high deductible health plans “was associated with minimal or no reductions in controller medication use for children and adults and no change in asthma exacerbations,” suggesting a potential benefit from...
Authors noted that enrollment in high deductible health plans “was associated with minimal or no reductions in controller medication use for children and adults and no change in asthma exacerbations,” suggesting a potential benefit from...
Authors noted that enrollment in...
10/26/2021
First Report Managed Care
Cancer Screening Cessation for Older Adults
06/26/2013
There are many educational efforts designed to increase the rates of screening for cancer, which is an important part of standard medical care. However, the balance of the risks and benefits of screening are affected by situations such as...
There are many educational efforts designed to increase the rates of screening for cancer, which is an important part of standard medical care. However, the balance of the risks and benefits of screening are affected by situations such as...
There are many educational...
06/26/2013
First Report Managed Care
News
Mylan gets approval for generic Effexor XR
06/08/2011
06/08/2011
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

September 2014 Volume 11 Issue 9

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use